OTCMKTS:PHGUF - Pharming Group Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.55 +0.04 (+2.65 %)
(As of 05/22/2018 04:00 PM ET)
Previous Close$1.51
Today's Range$1.55 - $1.55
52-Week Range$0.3620 - $1.96
Volume3,000 shs
Average Volume9,645 shs
Market Capitalization$874.31 million
P/E RatioN/A
Dividend YieldN/A
Beta3.25

About Pharming Group (OTCMKTS:PHGUF)

Pharming Group logoPharming Group N.V., a specialty pharmaceutical company, develops and produces human therapeutic proteins for the treatment of rare diseases and unmet medical needs. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of angioedema attacks in patients with acute hereditary angioedema (HAE) in Europe, the United States, Israel, European Union countries, Norway, Iceland, and Liechtenstein. It also engages in the development of recombinant human C1 inhibitor for treating HAE attacks; and recombinant human factor VIII (rhFVIII), a natural human blood clotting factor for treating haemophilia A. The company has a strategic collaboration with Shanghai Institute of Pharmaceutical Industry for the development, manufacture, and commercialization of new products based on the Pharming technology platform; and a partnership agreement with the China State Institute of Pharmaceutical Industry for the development of rhFVIII for the treatment of Haemophilia A. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Receive PHGUF News and Ratings via Email

Sign-up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Tobacco products
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PHGUF
CUSIPN/A
Phone31-71-524-7400

Debt

Debt-to-Equity Ratio3.14
Current Ratio1.51
Quick Ratio1.19

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$101.29 million
Price / Sales8.86
Cash FlowN/A
Price / CashN/A
Book Value$0.04 per share
Price / Book38.75

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-90,370,000.00
Net Margins-69.48%
Return on Equity-259.69%
Return on Assets-33.75%

Miscellaneous

Employees94
Outstanding Shares579,020,000

Pharming Group (OTCMKTS:PHGUF) Frequently Asked Questions

What is Pharming Group's stock symbol?

Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) released its earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. Pharming Group had a negative return on equity of 259.69% and a negative net margin of 69.48%. View Pharming Group's Earnings History.

When is Pharming Group's next earnings date?

Pharming Group is scheduled to release their next quarterly earnings announcement on Wednesday, May, 23rd 2018. View Earnings Estimates for Pharming Group.

Who are some of Pharming Group's key competitors?

Who are Pharming Group's key executives?

Pharming Group's management team includes the folowing people:
  • Dr. Sijmen de Vries M.D., MBA, Chairman of Management Board and Chief Exec. Officer (Age 59)
  • Mr. Robin Wright BA (Oxon), FCA., Chief Financial Officer and Member of Management Board (Age 54)
  • Dr. Bruno M. L. Giannetti M.D., Ph.D., Chief Operations Officer and Member of Management Board (Age 66)
  • Dr. Pericles Calias Ph.D., Chief Scientific Officer
  • Mr. Paul Th. Janssen MA MBA MSc, VP of Marketing & Sales (Age 49)

Has Pharming Group been receiving favorable news coverage?

News coverage about PHGUF stock has been trending somewhat negative on Tuesday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Pharming Group earned a media sentiment score of -0.02 on Accern's scale. They also gave news stories about the biotechnology company an impact score of 47.23 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Pharming Group?

Shares of PHGUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pharming Group's stock price today?

One share of PHGUF stock can currently be purchased for approximately $1.55.

How big of a company is Pharming Group?

Pharming Group has a market capitalization of $874.31 million and generates $101.29 million in revenue each year. Pharming Group employs 94 workers across the globe.

How can I contact Pharming Group?

Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The biotechnology company can be reached via phone at 31-71-524-7400 or via email at [email protected]


MarketBeat Community Rating for Pharming Group (PHGUF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  169
MarketBeat's community ratings are surveys of what our community members think about Pharming Group and other stocks. Vote "Outperform" if you believe PHGUF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHGUF will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pharming Group (OTCMKTS:PHGUF) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
2 Wall Street analysts have issued ratings and price targets for Pharming Group in the last 12 months. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Pharming Group (OTCMKTS:PHGUF) Consensus Price Target History

Price Target History for Pharming Group (OTCMKTS:PHGUF)

Pharming Group (OTCMKTS:PHGUF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
3/7/2018Roth CapitalReiterated RatingBuyView Rating Details
10/26/2017HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Pharming Group (OTCMKTS:PHGUF) Earnings History and Estimates Chart

Earnings by Quarter for Pharming Group (OTCMKTS:PHGUF)

Pharming Group (OTCMKTS:PHGUF) Earnings Estimates

Current Year EPS Consensus Estimate: $0.04 EPS
Next Year EPS Consensus Estimate: $0.11 EPS

Pharming Group (OTCMKTS PHGUF) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/23/2018        
10/26/2017Q3 2017($0.01)($0.02)$18.76 million$30.06 millionViewN/AView Earnings Details
7/27/2017Q2 2017($0.02)($0.06)$17.80 million$16.69 millionViewN/AView Earnings Details
5/17/2017Q1 2017($0.01)$11.48 million$16.47 millionViewN/AView Earnings Details
3/9/2017Q4 2016($0.02)$7.75 millionViewN/AView Earnings Details
10/27/2016Q3 2016($0.01)$3.82 millionViewN/AView Earnings Details
7/28/2016Q2 2016($0.01)($0.01)$2.75 million$2.24 millionViewN/AView Earnings Details
5/18/2016Q1 2016($0.01)($0.01)$2.58 million$2.44 millionViewN/AView Earnings Details
3/10/2016Q4 2015($0.01)$4.01 million$2.57 millionViewN/AView Earnings Details
10/28/2015Q3 2015($0.01)$4.97 million$3.61 millionViewN/AView Earnings Details
7/30/2015Q2 2015($0.01)$2.12 million$3.82 millionViewN/AView Earnings Details
3/5/2015$0.04$0.05ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Pharming Group (OTCMKTS:PHGUF) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Pharming Group (OTCMKTS PHGUF) Insider Trading and Institutional Ownership History

Insider Trading History for Pharming Group (OTCMKTS:PHGUF)

Pharming Group (OTCMKTS PHGUF) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Pharming Group (OTCMKTS PHGUF) News Headlines

Source:
DateHeadline
Lundbeck (HLUYY) and Pharming Group (PHGUF) Critical SurveyLundbeck (HLUYY) and Pharming Group (PHGUF) Critical Survey
www.americanbankingnews.com - May 20 at 9:08 PM
Head to Head Analysis: Pharming Group (PHGUF) & Lundbeck (HLUYY)Head to Head Analysis: Pharming Group (PHGUF) & Lundbeck (HLUYY)
www.americanbankingnews.com - May 17 at 1:31 PM
Pharming Group Interim Report on Financial Results for the First Quarter 2018Pharming Group Interim Report on Financial Results for the First Quarter 2018
www.prnewswire.com - May 17 at 1:51 AM
Indivior (INVVY) versus Pharming Group (PHGUF) Head-To-Head ReviewIndivior (INVVY) versus Pharming Group (PHGUF) Head-To-Head Review
www.americanbankingnews.com - May 12 at 3:28 PM
Head to Head Contrast: Pharming Group (PHGUF) and Turning Point Brands (TPB)Head to Head Contrast: Pharming Group (PHGUF) and Turning Point Brands (TPB)
www.americanbankingnews.com - May 11 at 11:21 PM
Pharming Group NV.’s (AMS:PHARM) Shift From Loss To ProfitPharming Group NV.’s (AMS:PHARM) Shift From Loss To Profit
finance.yahoo.com - May 8 at 9:49 AM
British American Tobacco (BTI) & Pharming Group (PHGUF) Critical ReviewBritish American Tobacco (BTI) & Pharming Group (PHGUF) Critical Review
www.americanbankingnews.com - May 2 at 1:08 AM
Critical Review: ADOCIA (ADOCY) vs. Pharming Group (PHGUF)Critical Review: ADOCIA (ADOCY) vs. Pharming Group (PHGUF)
www.americanbankingnews.com - May 1 at 5:31 AM
Pharming Group (PHGUF) Rating Increased to Hold at Zacks Investment ResearchPharming Group (PHGUF) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - April 9 at 1:55 PM
Pharming Group (PHGUF) Lifted to Buy at Zacks Investment ResearchPharming Group (PHGUF) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - April 6 at 6:29 PM
Pharming Group (PHGUF) Downgraded by Zacks Investment ResearchPharming Group (PHGUF) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 4 at 10:54 PM
Zacks Investment Research Lowers Pharming Group (PHGUF) to SellZacks Investment Research Lowers Pharming Group (PHGUF) to Sell
www.americanbankingnews.com - March 29 at 5:48 PM
Pharming Enters the Euronext Amsterdam SmallCap-index (AScX)Pharming Enters the Euronext Amsterdam SmallCap-index (AScX)
www.prnewswire.com - March 15 at 3:13 AM
Pharming Group (PHGUF) Cut to Hold at Zacks Investment ResearchPharming Group (PHGUF) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - March 10 at 6:06 AM
Pharming Groups (PHGUF) "Buy" Rating Reiterated at Roth CapitalPharming Group's (PHGUF) "Buy" Rating Reiterated at Roth Capital
www.americanbankingnews.com - March 8 at 7:28 AM
Pharming Group Report on Preliminary Financial Results for 2017Pharming Group Report on Preliminary Financial Results for 2017
www.prnewswire.com - March 7 at 1:33 AM
Pharming Group (PHGUF) Upgraded by Zacks Investment Research to "Strong-Buy"Pharming Group (PHGUF) Upgraded by Zacks Investment Research to "Strong-Buy"
www.americanbankingnews.com - January 20 at 9:24 AM
Pharming Group (PHGUF) Rating Lowered to Hold at Zacks Investment ResearchPharming Group (PHGUF) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - December 5 at 6:58 AM
Pharming Group (PHGUF) Rating Lowered to Sell at ValuEnginePharming Group (PHGUF) Rating Lowered to Sell at ValuEngine
www.americanbankingnews.com - December 2 at 9:10 PM

SEC Filings

Pharming Group (OTCMKTS:PHGUF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Pharming Group (OTCMKTS PHGUF) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.